Bartelink, I.H.; van de Stadt, E.A.; Leeuwerik, A.F.; Thijssen, V.L.J.L.; Hupsel, J.R.I.; van den Nieuwendijk, J.F.; Bahce, I.; Yaqub, M.; Hendrikse, N.H.
Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients. Pharmaceuticals 2022, 15, 796.
https://doi.org/10.3390/ph15070796
AMA Style
Bartelink IH, van de Stadt EA, Leeuwerik AF, Thijssen VLJL, Hupsel JRI, van den Nieuwendijk JF, Bahce I, Yaqub M, Hendrikse NH.
Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients. Pharmaceuticals. 2022; 15(7):796.
https://doi.org/10.3390/ph15070796
Chicago/Turabian Style
Bartelink, I. H., E. A. van de Stadt, A. F. Leeuwerik, V. L. J. L. Thijssen, J. R. I. Hupsel, J. F. van den Nieuwendijk, I. Bahce, M. Yaqub, and N. H. Hendrikse.
2022. "Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients" Pharmaceuticals 15, no. 7: 796.
https://doi.org/10.3390/ph15070796
APA Style
Bartelink, I. H., van de Stadt, E. A., Leeuwerik, A. F., Thijssen, V. L. J. L., Hupsel, J. R. I., van den Nieuwendijk, J. F., Bahce, I., Yaqub, M., & Hendrikse, N. H.
(2022). Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients. Pharmaceuticals, 15(7), 796.
https://doi.org/10.3390/ph15070796